George V. Rebec Chancellors' Professor Department of Psychology & Director, Program in Neural Science Indiana University Bloomington, Indiana  47405  USA

Postdoctoral Fellow
Department of Psychiatry

University of California - San Diego

Ph.D. 1975

Biopsychology

University of Colorado

M.A. 1974

Biopsychology

University of Colorado

A.B. 1971

Psychology

Villanova University

Book Reviews
1. Rebec, G. V. An introduction to the mind. Contemporary Psychology, 23:260-261, 1978. Review of Blakemore, C. Mechanics of the Mind. New York: Cambridge University Press, 1977.

2. Rebec, G. V. A basic text with some basic problems. Contemporary Psychology, 23: 671-672, 1978. Review of Bruce, R. L. Fundamentals of Physiological Psychology. New York: Holt, Rinehart and Winston, 1977.

3. Rebec, G. V. Applied psychopharmacology. Contemporary Psychology, 26: 700, 1981. Review of Levenson, A. J. Basic Psychopharmacology. New York: Springer, 1981.

4. Rebec, G. V. What's new in psychoneuroendocrinology. Contemporary Psychology, 28:55, 1983. Review of Collu, R., Ducharme, J. R., Barbeau, A. and Tolis, G., Eds. Brain Neurotransmitters and Hormones. New York: Raven Press, 1982.

5. Rebec, G. V. More than an update. Contemporary Psychology, 30:134-135, 1985. Review of Iversen, L. L., Iversen, S. D. and Snyder, S. H., Eds. Handbook of Psychopharmacology, Volume 18: Drugs, Neurotransmitters, and Behavior. New York: Plenum Press, 1984.

6. Rebec, G. V. An integrative approach to modeling drug effects. Contemporary Psychology, 38:158, 1993. Review of Willner, Paul, Ed. Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. Cambridge, England: Cambridge University Press, 1991.

Textbooks and Textbook Chapters
1. Rebec, G. V. Reinforcement and self-stimulation (contributed chapter). In Groves, P. M. and Schlesinger, K. S., An Introduction to Biological Psychology. Dubuque, Iowa: William C. Brown, 1979.

2. Rebec, G. V. Sleep, dreaming, and arousal (contributed chapter). In Groves, P. M. and Schlesinger, K. S., An Introduction to Biological Psychology. Dubuque, Iowa: William C. Brown, 1979.

3. Rebec, G. V. Abnormal behavior (contributed chapter). In Groves, P. M. and Schlesinger, K. D., An Introduction to Biological Psychology. Dubuque, Iowa: William C. Brown, 1979.

4. Rebec, G. V., Instructor's Manual for Psychology, The Science of Behavior. Boston: Allyn and Bacon, 1984, (172 pp.).

5. Groves, P. M. and Rebec, G. V. Introduction To Biological Psychology (Third Edition). Dubuque, Iowa: William C. Brown, 1988 (623 pp.).

6. Rebec, G. V. and Groves, P. M. Instructor's Manual for Introduction to Biological Psychology (Third Edition). Dubuque, Iowa: William C. Brown, 1988 (147 pp.).

7. Groves, P. M. and Rebec, G. V. Introduction to Biological Psychology (Fourth Edition). Dubuque, Iowa: William C. Brown, 1992 (712 pp.).

8. Rebec, G. V. and Groves, P. M. Instructor's Manual for Introduction to Biological Psychology (Fourth Edition). Dubuque, Iowa: William C. Brown, 1992 (105 pp.)

Research Articles and Monographs
1. Groves, P. M., Miller, S. W., Parker, M. V., and Rebec, G. V. Organization by sensory modality in the reticular formation of the rat. Brain Research, 54: 207-224, 1973.

2. Groves, P. M., Rebec, G. V., and Segal, D. S. The action of d-amphetamine on spontaneous activity in the caudate nucleus and reticular formation of the rat. Behavioral Biology, 11:33-47, 1974.

3. Rebec, G. V. and Groves, P. M. Differential effects of the optical isomers of amphetamine on neuronal activity in the reticular formation and caudate nucleus of the rat. Brain Research, 83:301-318, 1975.

4. Rebec, G. V. and Groves, P. M. Apparent feedback from the caudate nucleus to the substantia nigra following amphetamine administration. Neuropharmacology, 14:275-282, 1975.

5. Groves, P. M., Rebec, G. V., and Harvey, J. A. Alteration of the effects of (+)-amphetamine on neuronal activity in the striatum following lesions of the nigrostriatal bundle. Neuropharmacology, 14:369-376, 1975.

6. Groves, P. M., Wilson, C. J., Young, S. J., and Rebec, G. V. Self-inhibition by dopaminergic neurons: An alternative to the "neuronal feedback loop" hypothesis for the mode of action of certain psychotropic drugs. Science, 190:522-529, 1975.

7. Rebec, G. V. Neurophysiological correlates of long-term amphetamine treatment in rats. Doctoral dissertation, University of Colorado, Boulder, 1975.

8. Groves, P. M. and Rebec, G. V. Biochemistry and behavior: Some central actions of amphetamine and antipsychotic drugs. Annual Review of Psychology, 27:91-127, 1976.

9. Rebec, G. V. and Groves, P. M. Enhancement of effects of dopaminergic agonists on neuronal activity in the caudate-putamen of the rat following long-term d-amphetamine administration. Pharmacology, Biochemistry and Behavior, 5:349-357, 1976.

10. Groves, P. M. and Rebec, G. V. Changes in neuronal activity in the neostriatum and reticular formation following acute or long-term amphetamine administration. In Cocaine and Other Stimulants, E. H. Ellinwood, Jr. and M. M. Kilbey, Eds., Plenum Press, New York, pp. 269-301, 1977.

11. Bashore, T. R., Rebec, G. V. and Groves, P. M. Alterations of spontaneous neuronal activity in the caudate-putamen, nucleus accumbens, and amygdaloid complex of rats produced by D-amphetamine. Pharmacology, Biochemistry, and Behavior, 8:467-474, 1978.

12. Rebec, G. V. and Segal, D. S. Dose-dependent biphasic alterations in the spontaneous activity of neurons in the rat neostriatum produced by d-amphetamine and methylphenidate. Brain Res., 150:353-366, 1978.

13. Rebec, G. V. and Segal, D. S. Enhanced responsiveness to intraventricular infusion of amphetamine following its repeated systemic administration. Psychopharmacology, 62:101-102, 1979.

14. Rebec, G. V., Bashore, T. R., Zimmerman, K. S., and Alloway, K. S. "Classical" and "atypical" antipsychotic drugs: Differential antagonism of amphetamine- and apomorphine-induced alterations of spontaneous neuronal activity in the neostriatum and nucleus accumbens. Pharmacology, Biochemistry and Behavior, 11:529-538, 1979.

15. Rebec, G. V., Bashore, T. R., Zimmerman, K. S., and Alloway, K. D. Neostriatal and mesolimbic neurons: Dose-dependent effects of clozapine. Neuropharmacology, 19:281-288, 1980.

16. Rebec, G. V. and Segal, D. S. Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment. Pharmacology, Biochemistry and Behavior, 13:793-797, 1980.

17. Rebec, G. V. and Zimmerman, K. S. Opposite effects of d-amphetamine on spontaneous neuronal activity in the neostriatum and nucleus accumbens. Brain Research, 201:485-491, 1980.

18. Rebec, G. V., Alloway, K. D., and Bashore, T. R. Differential action of classical and atypical antipsychotic drugs on spontaneous neuronal activity in the amygdaloid complex. Pharmacology, Biochemistry and Behavior, 14:49-56, 1981.

19. Rebec, G. V., Alloway, K. D., and Curtis, S. D. Apparent serotonergic modulation of the dose-dependent biphasic response of neostriatal neurons produced by d-amphetamine. Brain Research, 210:277-289, 1981.

20. Rebec, G. V. and Bashore, T. R. Comments on "Amphetamine models of paranoid schizophrenia": A precautionary note. Psychological Bulletin, 92:403-409, 1982.

21. Rebec, G. V., Peirson, E. E., McPherson, F. A., and Brugge, K. Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol. Psychopharmacology, 77:360-366, 1982.

22. Rebec, G. V. and Lee, E. H. Differential subsensitivity of dopaminergic and neostriatal neurons to apomorphine with long-term treatment, Brain Research, 250:188-192, 1982.

23. Rebec, G. V., Curtis, S. D., and Zimmerman, K. S. Dorsal raphe neurons: Self-inhibition by an amphetamine-induced release of endogenous serotonin. Brain Research, 251:374-379, 1982

24. Ewing, A. G., Alloway, K. D., Curtis, S. D., Dayton, M. A., Wightman R. M., and Rebec, G. V. Simultaneous electrochemical and unit recording measurements: Characterization of the effects of d-amphetamine and ascorbic acid on neostriatal neurons. Brain Research, 261:101-108, 1983.

25. Alloway, K. D. and Rebec, G. V. Shift from inhibition to excitation in the neostriatum but not in the nucleus accumbens following long-term amphetamine. Brain Research, 273:71-79, 1983.

26. Rebec, G. V. and Lee, E. H. Tolerance to amphetamine-induced inhibition of neuronal activity in the central amygdaloid nucleus. Pharmacology, Biochemistry and Behavior, 19:219-223, 1983.

27. Rebec, G. V. and Curtis, S. D. Reciprocal changes in the firing rate of neostriatal and dorsal raphe neurons following local infusions or systemic injections of d-amphetamine: Evidence for neostriatal heterogeneity. Journal of Neuroscience, 3:2240-2250, 1983.

28. Rebec, G. V., Gelman, J., Alloway, K. D., and Bashore, T. R. Cataleptogenic potency of the antipsychotic drugs is inversely correlated with neuronal activity in the amygdaloid complex of the rat. Pharmacology, Biochemistry and Behavior, 19:759-763, 1983.

29. Kamata, K. and Rebec, G. V. Dopaminergic and neostriatal neurons: Dose-dependent changes in sensitivity to amphetamine with long-term treatment. Neuropharmacology, 22:1377-1382, 1983.

30. Rebec, G. V. Auto-and postsynaptic dopamine receptors in the central nervous system. In Neuroreceptors in Health and Disease, J. Marwaha and W. Anderson, Eds., S. Karger AG, Basal, pp. 207-223, 1984.

31. Kamata, K. and Rebec, G. V. Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area. Life Sciences, 34:2419-2427, 1984.

32. Rebec, G. V. and Bashore, T. R. Critical issues in assessing the behavioral effects of amphetamine. Neuroscience and Biobehavioral Reviews, 8:153-159, 1984.

33. Alloway, K. D. and Rebec, G. V. Apomorphine-induced inhibition of neostriatal activity is enhanced by lesions induced by 6-hydroxydopamine but not by long-term administration of amphetamine. Neuropharmacology, 23:1033-1039, 1984.

34. Kamata, K. and Rebec, G. V. Nigral dopaminergic neurons: Differential sensitivity to apomorphine following long-term treatment with low and high doses of amphetamine. Brain Research, 321:147-150, 1984.

35. Kamata, K. and Rebec, G. V. Iontophoretic evidence for subsensitivity of postsynaptic dopamine receptors in the neostriatum following long-term amphetamine administration. European Journal of Pharmacology, 106:393-397, 1984.

36. Rebec, G. V., Centore, J. M., White, L. K., and Alloway, K. D. Ascorbic acid and the behavioral response to haloperidol: Implications for the action of antipsychotic drugs. Science, 227:438-440, 1985.

37. Kamata, K. and Rebec, G. V. Nigral reticulata neurons: Potentiation of responsiveness to amphetamine with long-term treatment. Brain Research, 332:188-193, 1985.

38. Gardiner, T. W., Armstrong-James, M., Caan, A. W., Wightman, R. M., and Rebec, G. V. Modulation of neostriatal activity by iontophoresis of ascorbic acid. Brain Research, 344:181-185, 1985.

39. Basse-Tomusk, A. E. and Rebec, G. V. Unilateral dopamine depletions attenuate the response of striatal neurons to systemic amphetamine in both hemispheres. Neuroscience, 16:845-850, 1985.

40. Rebec, G. V. and Anderson, G. D. Regional neuropharmacology of the antipsychotic drugs: Implications for the dopamine hypothesis of schizophrenia. Behavioral Assessment, 8:11-29, 1986.

41. Kamata, K., Wilson, R. L., Alloway, K. D., and Rebec, G. V. Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat. Brain Research, 362:331-338, 1986.

42. Wilson, R. L., Kamata, K., Bigelow, J. C., Rebec, G. V., and Wightman, R. M. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum. Brain Research, 370:393-396, 1986.

43. Anderson, G. D. and Rebec, G. V. Differential response of amygdaloid neurons to clozapine and haloperidol: Effects of repeated administration. Pharmacology, Biochemistry and Behavior, 24:1561-1566, 1986.

44. Wilson, R. L., Kamata, K., Wightman, R. M., and Rebec, G. V. Unilateral, intranigral infusions of amphetamine produce differential, bilateral changes in unit activity and extracellular levels of ascorbate in the neostriatum of the rat. Brain Research, 384:342-347, 1986.

45. Basse-Tomusk, A. E. and Rebec, G. V. Ipsapirone depresses neuronal activity in the dorsal raphe nucleus and hippocampal formation. European Journal of Pharmacology, 130:141-143, 1986.

46. Heidenreich, B. A., Basse-Tomusk, A. E., and Rebec, G. V. Serotonergic dorsal raphe neurons: Subsensitivity to amphetamine with long-term treatment. Neuropharmacology, 26:719-724, 1987.

47. Rebec, G. V. Long-term amphetamine administration: Changes in the firing rate of monoaminergic neurons and the release of ascorbate. In Inactivation of Hypersensitive Neurons, N. Chalzonitis and M. Gola, Eds., Alan R. Liss Publishers, New York, pp. 215-222, 1987.

48. Rebec, G. V. Electrophysiological pharmacology of amphetamine. In Neurobiology of Drug Abuse, J. Marwah, Ed., S. Karger AG, Basal, pp.1-33, 1987.

49. Kuhr, W., Wightman, R. M., and Rebec, G. V. Dopaminergic neurons: Simultaneous measurements of dopamine release and single-unit activity during stimulation of the medial forebrain bundle. Brain Research, 418:122-128, 1987.

50. White, L. K., Carpenter, M., Block, N., Basse-Tomusk, A., Gardiner, T. W., Rebec, G. V. Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism. Psychopharmacology, 94:284-287, 1988.

51. Anderson, G. D. and Rebec, G. V. Clozapine and haloperidol in the amygdaloid complex: Differential effects on dopamine transmission with long-term treatment. Biological Psychiatry, 23:497-506, 1988.

52. Gardiner, T. W., Iverson, D. A., and Rebec, G. V. Heterogeneous responses of neostriatal neurons to amphetamine in freely moving rats. Brain Research, 463:268-274, 1988.

53. Rebec, G. V. and Curtis, S. D. Reciprocal zones of excitation and inhibition in the neostriatum. Synapse, 2:633-635, 1988.

54. Rebec, G. V. and Anderson, G. D. Unique effects of long-term clozapine, but not haloperidol, on dopamine transmission in the amygdaloid complex. In Pharmacology and Functional Regulation of Dopaminergic Neurons, P. M. Beart, G. N. Woodruff, D. M. Jackson, Eds., Macmillan, London, pp. 242-244, 1988.

55. Tschanz, J. T. and Rebec, G. V. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy. Pharmacology, Biochemistry and Behavior, 31:519-522, 1989.

56. Ciancone, M. T. and Rebec, G. V. A simple device for the reliable production of varnish-insulated, high impedance tungsten microelectrodes. Journal of Neuroscience Methods, 27:77-79, 1989.

57. Oh, C., Gardiner, T. W., and Rebec, G. V. Blockade of both D1 and D2 dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum. Brain Research, 480:184-189, 1989.

58. Haracz, J. L., Tschanz, J. T., Greenberg, J., and Rebec, G. V. Amphetamine-induced excitations predominate in single neostriatal neurons showing motor-related activity. Brain Research, 489:365-368, 1989.

59. Heidenreich, B. A. and Rebec, G. V. Serotonergic dorsal raphe neurons: Changes in spontaneous neuronal activity and responsiveness to 5-MeODMT following long-term amphetamine administration. Neuroscience Letters, 103:81-86 1989.

60. Rebec, G. V., Kraft, M. E., Langley, P. E., and Ciancone, M. T. In vivo voltammetry in freely moving animals: Monitoring ascorbate release during acute and chronic amphetamine. Current Separations, 9:93, 1989.

61. Rebec, G. V., Oh, C., and Gardiner, T. W. Amphetamine, ascorbate, and dopamine: Neuronal and behavioral interactions. In Symposia in Neuroscience, G. Biggio, P. F. Spano, G. Toffano, and G. L. Gessa, Eds., Liviana Press-Springer Verlag, Padova, 1989.

62. Basse-Tomusk, A. and Rebec, G. V. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum. Pharmacology, Biochemistry, and Behavior, 35:55-60, 1990.

63. White, L. K., Maurer, M., Kraft, M. E., Oh, C., and Rebec, G. V. Intrastriatal infusions of ascorbate antagonize the behavioral response to amphetamine. Pharmacology, Biochemistry, and Behavior, 36:485-489, 1990.

64. Wiedemann, D. J., Basse-Tomusk, A., Wilson, R. L., Rebec, G. V., and Wightman, R. M. Interference by DOPAC and ascorbate during attempts to measure drug-induced changes in neostriatal dopamine with nafion-coated, carbon-fiber electrodes. Journal of Neuroscience Methods, 35:9-18, 1990

65. Pierce, R. C. and Rebec, G. V. Stimulation of both D1 and D2 dopamine receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats. European Journal of Pharmacology, 191:295-302, 1990.

66. Basse-Tomusk, A. and Rebec, G. V. Regional distribution of ascorbate and 3,4-dihydroxyphenylacetic acid (DOPAC) in rat neostriatum. Brain Research, 538:29-35, 1991.

67. Rebec, G. V. Changes in brain and behavior produced by amphetamine: a perspective based on microdialysis, voltammetry, and single-unit electrophysiology in freely moving animals. In Biochemistry and Physiology of Substance Abuse, CRC Series Physiology of Drug Abuse, Volume III, R. R. Watson, Ed., CRC Press, Boca Raton, FL, pp. 93-115, 1991.

68. Rebec, G. V., Haracz, J. L., Tschanz, J. T., Wang, Z. and White, I. Responses of motor- and nonmotor-related neostriatal neurons to amphetamine and neuroleptic drugs. In Basal Ganglia III, Advances in Behavioral Biology, Vol. 39, G. Bernardi, Ed., Plenum Press, New York, pp. 463-470, 1991.

69. Pierce, R. C. and Rebec, G. V. In vivo voltammetry in freely moving rats: effects of dopamine agonists and neuroleptics on neostriatal ascorbate. Current Separations, 10:94-95, 1991.

70. Yount, S. E., Kraft, M. E., Pierce, R. C., Langley, P. E., and Rebec, G. V. Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats. Life Sciences, 49:1237-1244, 1991.

71. Pierce, R. C., Rowlett, J. K., Bardo, M. T., and Rebec, G. V. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding. Neuroscience, 45:373-378, 1991.

72. Tschanz, J. T., Haracz, J. L., Griffith, K. E., and Rebec, G. V. Bilateral cortical ablations attenuate amphetamine-induced excitations of neostriatal motor-related neurons in freely moving rats. Neuroscience Letters, 134:127-130, 1991.

73. White, I. M., Ciancone, M. T., Haracz, J. L., and Rebec, G. V. A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802, Pharmacology, Biochemistry, and Behavior, 41:29-35, 1991.

74. Rebec, G. V. Neuropharmacology of amphetamine: changes in the activity of striatal neurons during behavior. In Drugs of Abuse and Neurobiology, CRC Series Physiology of Drug Abuse, R. R. Watson, Ed., CRC Press, Boca Raton, FL, pp. 149-174, 1992.

75. Pierce, R. C., and Rebec, G. V. Dopamine-, NMDA-, and sigma-receptor antagonists exert differential effects on neostriatal ascorbate and DOPAC in awake, behaving rats. Brain Research, 579:59-66, 1992.

76. Rebec, G. V. From psychopharmacology to neuropsychopharmacology: adapting behavioral terminology to neural events. Behavioral and Brain Sciences, 15:287-288, 1992.

77. Pierce, R. C., Wang, Z., Heidenreich, B. A., Langley, P. E., and Rebec, G. V. An easily fabricated electrode holder for voltammetric and electrophysiological recordings from awake, behaving rats. Kopf Carrier, 32:1-5, 1992.

78. Wang, Z., Haracz, J. L., and Rebec, G. V. BMY-14802, a sigma ligand and potential antipsychotic drugs reverses amphetamine-induced changes in neostriatal single-unit activity in freely moving rats. Synapse, 12:312-321, 1992.

79. Pierce, R. C., Miller, D. M., Reising, D., and Rebec, G. V. Unilateral neostriatal kainate, but not 6-OHDA lesions, block dopamine agonist-induced ascorbate release in the neostriatum of freely-moving rats. Brain Research, 597:138-143, 1992.

80. Haracz, J. L., Tschanz, J. T., Wang, Z., White, I. M., and Rebec, G. V. Striatal single-unit responses to amphetamine and neuroleptics in freely moving rats. Neuroscience and Biobehavioral Reviews, 17:1-12, 1993.

81. Rebec, G. V., Langley, P. E., Pierce, R. C., Wang, Z., and Heidenreich, B. A. A simple micromanipulator for multiple uses in freely moving rats: electrophysiology, voltammetry, and simultaneous intracerebral infusions. Journal of Neuroscience Methods, 47:53-59, 1993.

82. White, I. M. and Rebec, G. V. Responses of rat striatal neurons during performance of a lever-release version of the conditioned avoidance response task. Brain Research, 616:71-82, 1993.

83. Rosa-Kenig, A., Puotz, J. K., and Rebec, G. V. The involvement of D1 and D2 dopamine receptors in amphetamine-induced changes in striatal unit activity in behaving rats. Brain Research, 619:347-351, 1993.

84. Pierce, R. C., and Rebec, G. V. Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via non-dopaminergic mechanisms. Journal of Neuroscience, 13:4272-4280, 1993

85. Wang, Z., and Rebec, G. V. Neuronal and behavioral correlates of intrastriatal infusions of amphetamine in freely moving rats. Brain Research, 627:79-88, 1993

86. White, I. M., and Rebec, G. V. Performance on a lever-release, conditioned avoidance response task involves both D1 and D2 dopamine receptors. European Journal of Pharmacol, 253:167-169, 1994.

87. Rebec, G. V., Rosa-Kenig, A., Haracz, J. L., Tschanz, J. T., Griffith, K. E., Wang, Z., and Puotz, J. K. Cortical and dopaminergic regulation of amphetamine-induced changes in striatal single-unit activity in awake, behaving rats. In Basal Ganglia IV, Advances in Behavioral Biology, Vol. 40, Percheron, G., and McKenzie, J. S. (Eds.), Plenum Press, New York, pp. 457-463, 1994.

88. Tschanz, J. T., Griffith, K. E., Haracz, J. L., and Rebec, G. V. Cortical lesions attenuate the opposing effects of amphetamine and haloperidol on neostriatal neurons in freely moving rats. European Journal of Pharmacology, 257:161-167, 1994.

89. White, I. M., Miller, D. W., White, W., Dike, G. L., Rebec, G. V., and Steinmetz, J. E. Neuronal activity in rabbit neostriatum during classical eyelid conditioning. Experimental Brain Research, 99:179-190, 1994.

90. Heidenreich, B. A., Trytek, E., Schroeder, D. M., Sengelaub, D. R., and Rebec, G. V. A methodology for determining the patch-matrix compartmental location of extracellular single-unit recordings in the striatum of freely moving rats. Journal of Neuroscience Methods, 52:169-174, 1994.

91. Rebec, G. V. and Pierce, R. C. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Progress in Neurobiology, 43:537-565, 1994.

92. Pierce, R. C., Clemens, A. J., Grabner, C. P., and Rebec, G. V. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-corticoneostriatal loop. Journal of Neurochemistry, 63:1499-1507, 1994.

93. Pierce, R. C., Clemens, A. J., Shapiro, L. A., and Rebec, G. V. Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats. Psychopharmacology, 116:103-109, 1994.

94. Hamilton, E. J., Anderson, S. C., Austin, D. R., Near, J., Rebec, G. V., and Russel, R. V. Dopaminergic neural activity and contrived leisure experiences. Leisure Research Institute, Occasional Paper Series, 1:1-15, 1994.

95. White, I. M., Christensen, J. R., Flory, G. S., Miller, D. W. and Rebec, G. V. Amphetamine, cocaine, and dizocilpine enhance performance on a lever-release, conditioned avoidance response task in rats. Psychopharmacology, 118:324-331, 1995.

96. Pierce, R. C. and Rebec, G. V. Iontophoresis in the neostriatum of awake, unrestrained rats: differential effects of dopamine, glutamate, and ascorbate on motor- and nonmotor-related neurons. Neuroscience, 67:313-324, 1995.

97. Pierce, R. C., Rowlett, J. K., Rebec, G. V., and Bardo, M. T. Ascorbate potentiates amphetamine-induced conditioned place preference and forebrain dopamine release in rats. Brain Research, 688:21-26, 1995.

98. White, I. M., Flory, G. S., Hooper, K. C., Speciale, J., Banks, D. A., and Rebec, G. V. Phencyclidine-induced excitation of striatal neurons in behaving rats: reversal by haloperidol and clozapine. Journal of Neural Transmission, 102:99-112, 1995.

99. White, I. M. and Rebec, G. V. A lever-release version of the conditioned avoidance response (CAR) paradigm for assessing the neuronal mechanisms of action of antipsychotic drugs. Neuroscience Protocols, Module 6:1-15, 1995.

100. Kiyatkin, E. A. and Rebec, G. V. Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. Journal of Neurophysiology, 75:142-153, 1996.

101. Trytek, E. S., White, I. W., Schroeder, D. M., Heidenreich, B. A., and Rebec, G. V. Localization of motor- and nonmotor-related neurons within the matrix-striosome organization of rat striatum. Brain Research, 707:221-227, 1996.

102. Wang. Z. and Rebec, G. V. Amygdaloid neurons respond to clozapine rather than haloperidol in behaving rats pretreated with intra-amygdaloid amphetamine. Brain Research, 711:64-72, 1996.

103. Kiyatkin, E. A. and Rebec, G. V. Modulatory action of dopamine on acetylcholine-responsive striatal and accumbal neurons in awake, unrestrained rats. Brain Research, 713:70-78, 1996.

104. Rebec, G. V., Pierce, R. C., and Kiyatkin, E. A. Modulation of glutamate-induced excitation of striatal neurons by dopamine iontophoresis in awake, unrestrained rats. In: The Basal Ganglia V, Ohye, C., Kimura, M., and McKenzie, J. (eds.), Plenum Press, NY, pp.395-399, 1996.

105. Garris, P. A., Christensen, J. R. C., Rebec, G. V., and Wightman, R. M. Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. Journal of Neurochemistry, 68:152-161, 1997.

106. Rebec, G. V., Grabner, C. P., Pierce, R. C., Bardo, M. T. Transient increases in catecholaminergic activity in the medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience, 76:707-714, 1997.

107. Rebec, G. V., White, I. M. and Puotz, J. K. Responses of neurons in dorsal striatum during amphetamine-induced focused stereotypy. Psychopharmacology, 130:343-351, 1997.

108. Kiyatkin, E. A. and Rebec, G. V. Activity of presumed dopamine neurons in the ventral tegmental area during heroin self-administration. NeuroReport, 8:2581-2585, 1997.

109. Kiyatkin, E. A. and Rebec, G. V. Iontophoresis of amphetamine in the neostriatum and nucleus accumbens of awake, unrestrained rats. Brain Research, 771:14-24, 1997.

110. Rebec, G. V., Ascorbate: an antioxidant neuroprotectant and extracellular neuromodulator. In: Metals and Oxidative Damage in Neurological Disorders, Connor, J. R. (ed.), Plenum Press, NY, pp. 149-173, 1997.

111. Hooper, K. C., Banks, D. A., Stordahl, L. J., White, I. M., and Rebec, G. V. Quinpirole inhibits striatal and excites pallidal neurons in freely moving rats, Neuroscience Letters, 237:69-72, 1997.

112. Rebec, G. V., Christensen, J. R. C., Guerra, C., and Bardo, M. T. Regional and temporal differences in dopamine efflux in the nucleus accumbens during free-choice novelty, Brain Research, 776:61-67, 1997.  (Abstract)

113. Rebec, G. V. Dopamine, glutamate and behavioral correlates of striatal neuronal activity. In: Catecholamines: Bridging Basic Science with Clinical Medicine, Goldstein, D. (ed.), Academic Press, San Diego, CA, pp. 737-740, 1998.

114. Rebec, G. V. Real-time assessments of dopamine function during behavior: Single-unit recording, iontophoresis, and fast-scan cyclic voltammetry in awake, unrestrained rats. Alcoholism: Clinical and Experimental Research, 22:32-40, 1998.

115. Kiyatkin, E. A. and Rebec, G. V. Heterogeneity of ventral tegmental area neurons: single-unit recording and iontophoresis in awake, unrestrained rats. Neuroscience, 85:1285-1309, 1998.

116. Haracz, J. L., Tschanz, J. T., Wang, Z., Griffith, K. G., and Rebec, G. V. Amphetamine effects on striatal neurons: implications for models of dopamine function. Neuroscience and Biobehavioral Reviews, 22:613-622, 1998.

117. Wang, Z. and Rebec, G. V. Neuroethological assessment of amphetamine and neuroleptic drugs in the amygdala and nucleus accumbens: implications for mesolimbic functioning. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 22:883-905, 1998.

118. Kosobud, A. E. K., Pecoraro, N. C., Rebec, G. V., and Timberlake, W. Circadian activity precedes daily methamphetamine injections in the rat. Neuroscience Letters, 250:99-102, 1998.

119. Rebec, G. V. Behavioral Pharmacology of Amphetamines. In: Handbook of Substance Abuse: Neurobehavioral Pharmacology, Tarter, R. E., Ammerman, R. T., Ott, P. J. (ed.), Plenum Press, NY, pp. 515-527, 1998

120. White, I. M., Doubles, L. and Rebec, G. V. Cocaine-induced activation of striatal neurons during focused stereotypy in rats. Brain Research, 810:146-152, 1998.

121. Kiyatkin, E. A. and Rebec, G. V. Ascorbate modulates glutamate-induced excitations of striatal neurons. Brain Research, 812:14-22, 1998.

122. Rebec. G. V. Stimulants and motor-related striatal neuronal activity. In: Brain Dynamics and the Striatal Complex, Miller, R. and Wickens, J. R. (eds.), Conceptual Advances in Brain Research Series, Gordon and Breach, Reading, pp. 51-63, 1999.

123. Kiyatkin, E. A. and Rebec, G. V. Modulation of striatal neuronal activity by glutamate and GABA: iontophoresis in awake, unrestrained rats. Brain Research, 822:88-106, 1999.

124. Kiyatkin, E. A. and Rebec, G. V. Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats. Journal of Neuroscience, 19:3594-3609, 1999.  (Abstract | Full Text | PDF reprint)

125. Gulley, J. M. and Rebec, G. V. Modulatory effects of ascorbate, alone or with haloperidol, on a lever-release conditioned avoidance response task. Pharmacology, Biochemistry and Behavior, 63:125-129, 1999.

126. Gulley, J. M., Kuwajima, M., Mayhill, E., and Rebec, G. V. Behavior-related changes in the activity of substantia nigra pars reticulata neurons in freely moving rats. Brain Research, 845:68-76, 1999.  (Abstract)

127. Christensen, J. C., Wang, Z. and Rebec, G. V. GABA infusion in substantia nigra pars reticulata inhibits ascorbate release in ipsilateral striatum. Neuroscience Letters, 280: 191-194, 2000.

128. Kiyatkin, E. A. and Rebec, G. V. Dopamine-independent action of cocaine on striatal and accumbal neurons. European Journal of Neuroscience, 12:1789-1800, 2000.  (Abstract)

129. Kiyatkin, E. A., Kiyatkin, D. E., and Rebec, G. V. Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats. Neuroscience, 98:729-741, 2000.  (Abstract)

130. Tinsley, M. R., Rebec, G. V., and Timberlake, W. Facilitation of preparatory behavior in an artificial prey paradigm by D1 dopamine receptor activation. Behavioural Brain Research, 114:23-30, 2000.

131. Heidenreich, B. A. and Rebec, G. V. Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons. Synapse, 38:80-86, 2000.

132. Rebec, G. V. and Kiyatkin, E. A. Real-time assessment of cocaine-induced dopamine uptake inhibition in freely behaving rats. Proceedings of the IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering, 1:58-59, 2000.

133. Rebec, G. V. and Wang, Z. Microtechnology for monitoring real-time electrical and chemical events at the neuronal level in freely behaving animals. Proceedings of the IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering, 2:511-512, 2000.

134. Pecoraro, N. C., Kosobud, A. E. K., Rebec, G. V., and Timberlake, W. D. Long T methamphetamine schedules produce circadian ensuing drug activity in rats. Physiology and Behavior, 71:95-106, 2000.

135. Rebec, G. V. Cocaine. In: Encyclopedia of Psychology [American Psychological Association], Kazdin, A. E. (Ed.), Oxford University Press, 2000.

136. Rebec, G. V. and Wang, Z. Behavioral activation in rats require endogenous ascorbate release in striatum, Journal of Neuroscience, 21:668-675, 2001.

137. Kiyatkin, E. A. and Rebec, G. V. Impulse activity of ventral tegmental area neurons during heroin self-administration in rats, Neuroscience, 102: 565-580, 2001.

138. Teagarden, M. A. and Rebec, G. V. Effects of long-term haloperidol treatment on glutamate-evoked ascorbate release in rat striatum. European Journal of Pharmacology, 418:213-216, 2001.

139. Rebec, G. V. Cocaine and amphetamines. In: Encyclopedia of Life Sciences, in press.

140. Rebec, G. V. and Kiyatkin, E. A. Differential modulation of single-unit activity in the striatum of freely behaving rats by D1 and D2 dopamine receptors. In: The Basal Ganglia VI, DeLong, M., Katai, S. and Graybiel, A. M. (eds.), Kluwer-Plenum Press, NY, in press.

141. Tinsley, M. R., Rebec, G. V., and Timberlake, W. Facilitation of efficient search of an unbaited radial-arm maze by D1, but not D2, dopamine receptors. Pharmacology, Biochemistry, and Behavior, in press.

142. Garris, P. A., Boudygin, E., Phillips, P. E. M., Trafton, B. J., Robinson, D. L., Bergstrom, B. P., Rebec, G. V., and Wightman, R. M. Drug-induced stereotypy and catalepsy are tightly correlated with striatal dopamine measured by in vivo voltammetry, submitted.

143. Kebabian, C. E., Kosobud, A. E. K., and Rebec, G. V. Nitrous oxide acutely suppresses ethanol consumption in HAD and P rats, submitted.

144. Rebec, G. V. Addiction. In: Encyclopedia of Cognitive Science, Macmillan Reference Ltd., London, submitted.

145. Gulley, J. M., Kosobud, A. E. K., and Rebec, G. V. Behavior-related modulation of substantia nigra pars reticulata neurons in rats performing a conditioned reinforcement task, submitted.

146. Rebec, G. V., Barton, S. J., and Ennis, M. D. Dysregulation of ascorbate in the striatum of behaving mice expressing the huntington¹s disease gene, submitted.

147. Sandstrom, M. I. and Rebec, G. V. Characterization of striatal activity in conscious rats: Contribution of NMDA and AMPA/kainate glutamate receptors to maintenance of both spontaneous and glutamate-driven firing. submitted.

148. Garris, P. A. and Rebec, G. V. Toward a functional dopamine neurotransmission of the nucleus accumbens, submitted.

149. Gulley, J. M., Kosobud, A. E. K., and Rebec, G. V. Amphetamine inhibits behavior-related neuronal responses in substantia nigra pars reticulata of rats working for sucrose reinforcement, submitted.

[PubMed search for GV Rebec publications]

1978-1979       Summer Faculty Fellowship Award, Indiana University
1979-1980       Lilly Endowment Teaching Award, Indiana University
1981-1985       Advisory Editor: Contemporary Psychology
1984,1986        National Institute on Mental Health Study Sections
1990               President's Award for Distinguished Teaching, Indiana University
1994               Appointed Fellow, American Association for the Advancement of Science
1997               Appointed Fellow, American Psychological Society
1994-1999       Treasurer, Association of Neuroscience Departments and Programs
1998-present    Editorial Board: Behavioural Brain Research
1998-present    National Institute on Drug Abuse, Training and Career Development Study Section, NIDA-K
1999               Appointed Chancellors' Professor of Psychology and
                       Member, Alliance of Distinguished-Rank Professors, Indiana University, Bloomington
1999               Teaching Excellence Recognition Award, Indiana University, Bloomington
2000               Teaching Excellence Recognition Award, Indiana University, Bloomington
2001               Trustees Teaching Award, Indiana University, Bloomington

| Faculty   | Adjunct Faculty   | Postdoc/Scientist   | Grad. Students   | CISAB Alumni

| Graduate Program   | Undergrad.Prog.   | REU Program   | Postdoc Info  : Members Only

| Speakers   | Local Calendar   | Conferences   | CISAB Lectures

| DO Stuff !   | GET Stuff !   | LEARN Stuff !   | Good Reads

| Careers   | Homework Help   | Media Resource   | Tech Problems?   | Useful Links

| Contact   | A.B. Bulletin   | © Notice   | Web Site Index